415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis

BACKGROUND: Isavuconazole (ISA) is a novel triazole antifungal approved for treating invasive aspergillosis and mucormycosis. While ISA is increasingly used for prophylaxis in hematologic malignancy patients when other azoles are contraindicated, there are currently limited data on breakthrough inva...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Open Forum Infect Dis
Päätekijät: DeVoe, Catherine, Fung, Monica, Schwartz, Brian, Doernberg, Sarah B, Lo, Mimi, Graff, Larissa, Tan, Marisela, Logan, Aaron, Babik, Jennifer, Chin-Hong, Peter
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253539/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.426
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia